Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups.

about

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma Cucurmin, anticancer, & antitumor perspectives: A comprehensive review.Long-term stabilisation of myeloma with curcumin.

P2860

Q37671719-F86C5559-ABA7-4E6D-ADD4-19D93BF0AA0F Q39016579-615742E2-DFD2-4024-9A73-A655F2D788F6 Q49736620-B099DD88-108B-4347-8D3A-4BFB91A9F82B

P2860

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups.

Item

http://www.wikidata.org/entity/Q38927737

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Curcumin induces cell death of ...... the poor prognosis subgroups.

@en

type

Item

label

Curcumin induces cell death of ...... the poor prognosis subgroups.

@en

prefLabel

Curcumin induces cell death of ...... the poor prognosis subgroups.

@en

P1476

Curcumin induces cell death of ...... y the poor prognosis subgroups

@en

P2093

Catherine Godon

http://www.w3.org/2001/XMLSchema#string

Catherine Pellat-Deceunynck

http://www.w3.org/2001/XMLSchema#string

Charlotte Kervoëlen

http://www.w3.org/2001/XMLSchema#string

Maxime Halliez

http://www.w3.org/2001/XMLSchema#string

Patricia Gomez-Bougie

http://www.w3.org/2001/XMLSchema#string

Sophie Maïga

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular pathogenesis of multiple myeloma: basic and clinical updates

Emerging Bcl-2 inhibitors for the treatment of cancer.

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

The molecular classification of multiple myeloma

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.

Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model

Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies.

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

P304

60-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/15384047.2014.986997

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martine Amiot

Philippe Moreau

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269772184

http://www.w3.org/2001/XMLSchema#string

P698

25517601

http://www.w3.org/2001/XMLSchema#string

P921

curcumin

P932

4622499

http://www.w3.org/2001/XMLSchema#string

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups.

about

P2860

P2860

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932